Cervical cancer is a preventable disease
World Cancer Day is an initiative to remind women of the importance of taking care of their health and getting regular check-ups, as cervical cancer can be asymptomatic for long periods of time.
Prevent this disease with a conscious approach to your health.
- 660k new cases of cervical cancer 2
- 350k deaths from cervical cancer 2
Over the past 10 years since 2012, the incidence rate has increased by 24.5%, while the mortality rate has risen by 29.6% 2,3![]()
However, with immune system disorders, this process accelerates to 5-10 years because the body's ability to fight the infection weakens 1![]()
- cervical dysplasia
-
- mild dysplasia (CIN-I)
- moderate dysplasia (CIN-II)
- severe dysplasia (CIN-III)
- leukoplakia with atypia
- erythroplakia
- adenomatosis
- long-term use of estrogen-progestin oral contraceptives
- early childbirth
- inflammatory processes (cervicitis)
- cervical injuries during abortions and childbirth
- hormonal and immune homeostasis disorders
- onset of sexual activity before the age of 16
- frequent change of sexual partners
- the presence of serious diseases in close relatives
- smoking
of HPV infection
- weakened immune system
- micro-injuries to the basal layer of the epithelium
- urinary and genital infections
- endometriosis
- bad habits
- frequent change of sexual partners
Cervical Cancer Risk Assessment Test
We have prepared a test 10 to help you identify your individual risk factors for developing cervical cancer. Take it to make your prevention strategy more targeted and personalized.
Important! This test is intended for women aged 21 to 69 who have had at least one sexual contact and have not undergone a hysterectomy with removal of the cervix![]()
RESULTS
Your answers indicate that you do not have the main risk factors for developing cervical cancer (CC) considered in this test.
The information you provided also indicates positive habits that, to varying degrees, reduce the likelihood of malignant changes in the cervix:
- You did not have sexual intercourse before the age of 18. Early sexual debut is considered a risk factor because it increases the likelihood of HPV infection.
- You have had only one sexual partner. Having multiple sexual partners increases the risk of HPV infection and, consequently, the risk of developing cervical cancer.
- You undergo screening regularly. You indicated that you have had a Pap smear or an HPV test within the past 5 years. Regular screening is one of the most important preventive measures against cervical cancer, as it allows precancerous changes to be detected and treated in a timely manner. The recommended screening interval may vary.
- You do not smoke. Smoking increases the risk of developing cervical cancer.
- You consume an adequate amount of fruits and vegetables.
Your answers indicate that you have one or more risk factors for developing cervical cancer (CC)
Risk factor is any condition or behavior that increases the likelihood of developing a disease. However, having a risk factor does not mean that you will necessarily develop cervical cancer.
Primary risk factor:
- You have a history of HPV infection. Infection with certain types of HPV is the most important risk factor for developing cervical cancer. Most women diagnosed with cervical cancer have been infected with this virus.
Secondary risk factors:
- You had at least one sexual contact before the age of 18. Sexual activity at a young age is considered a risk factor because it increases the likelihood of HPV infection
- You have had sexual contact with more than one partner. Having multiple sexual partners is considered a risk factor because it increases the likelihood of HPV infection
- You have HIV or AIDS. HIV infection, or any condition that weakens the immune system, increases the risk of HPV infection and reduces the body’s ability to clear the virus in women
- You have a history of chlamydia, which may increase the risk of developing cervical cancer
- Your close female relatives have had cases of cervical cancer or cervical dysplasia. Research suggests that certain genes may influence the body’s ability to fight HPV infection
- You are XX y. o. The likelihood of developing cervical cancer increases in midlife and gradually declines after the age of 50
- You smoke. Smoking increases the risk of developing cervical cancer
- You do not consume enough fruits and vegetables
- You have never had a Pap smear or an HPV test, or you had one more than 5 years ago. Skipping examinations or undergoing screening irregularly may result in missing precancerous changes in cervical cells
Your results also indicate positive habits that, to varying degrees, reduce the likelihood of developing cervical cancer:
- You did not have sexual intercourse before the age of 18. Early sexual debut is considered a risk factor because it increases the likelihood of HPV infection.
- You have had only one sexual partner. Having multiple sexual partners increases the risk of HPV infection and, consequently, the risk of developing cervical cancer.
- You undergo screening regularly. You indicated that you have had a Pap smear or an HPV test within the past 5 years. Regular screening is one of the most important preventive measures against cervical cancer, as it allows precancerous changes to be detected and treated in a timely manner. The recommended screening interval may vary.
- You do not smoke. Smoking increases the risk of developing cervical cancer.
- You consume an adequate amount of fruits and vegetables.
The main risk factor is HPV infection
Most cases of cervical cancer are associated with it.
How is it transmitted?
HPV is transmitted through close skin-to-skin contact, most commonly during sexual activity. The risk of infection increases if you began sexual activity at an early age, have had multiple sexual partners during your lifetime, or if your partner has had many sexual partners.
Not all HPV types are the same
There are more than 150 types of HPV. Some cause genital warts but not cancer. About two-thirds of all cervical cancer cases are caused by just two types — HPV 16 and 18. However, most women infected with these types do not develop cervical cancer, as the body often clears the infection on its own.
Asymptomatic course
HPV infection often has no symptoms, so a person may not know they are a carrier. Condoms reduce the risk of transmission but do not provide complete protection against HPV, as the virus can spread through contact with any infected area of skin. The most reliable ways to protect against HPV infection and the subsequent development of cervical cancer are timely HPV vaccination and regular screening.
Other factors that increase the risk of developing cervical cancer:
- Human immunodeficiency virus (HIV) infection or a weakened immune system HIV and any other condition that weakens the immune system (for example, taking immunosuppressive medications after organ transplantation or for the treatment of autoimmune diseases) increase the risk of HPV infection and, consequently, the subsequent development of cervical cancer in women.
- Chlamydia Recent studies suggest that past or current chlamydia infection may increase the risk of developing cervical cancer.
- Family history of cervical cancer or cervical dysplasia Women whose mothers or sisters have had cervical cancer or cervical dysplasia are at higher risk of developing cervical cancer themselves. This may be because some women inherit conditions that reduce their ability to fight HPV infection.
- Smoking Women who smoke develop cervical cancer approximately twice as often as non-smokers. Tobacco smoke contains numerous carcinogenic substances that circulate throughout the body in the bloodstream. Some of these substances have been detected in the cervical mucus of women who smoke.
- An unbalanced diet low in fruits and vegetables Women who consume few fruits and vegetables may be at a higher risk of developing cervical cancer.
- Irregular screening or lack of screening Regular Pap smears and HPV testing allow cervical cell changes to be detected and treated before they develop into cancer. Most cases of cervical cancer are diagnosed in women who have never been screened or who were screened irregularly.
Important!
The Cervical Cancer Risk Assessment Test is not a diagnostic tool. Its results do not constitute a diagnosis and do not replace an individual consultation with a qualified healthcare professional.
and diagnosis of cervical cancer
- HPV vaccination
- regular screenings
- adhering to medical recommendations and treating precancerous conditions of the cervix
- undergo annual preventive examinations with a gynecologist
- undergo annual cytological examination to detect atypical cells
- undergo colposcopic examination if changes are detected, as per the doctor's recommendation
- acceleration of the elimination of HPV-infected and transformed cells
- normalization of estradiol metabolism in HPV-infected cells
- enhancement of the nonspecific immune response to the infection
- maintaining a strong immune system
- use of condoms
- adjusting the diet to ensure sufficient intake of vitamins A, C, folic acid, and beta-carotene.
- quitting smoking
- limiting alcohol consumption
- Cervical cancer. 17.11.2023 // World Health Organization. [Electronic resource]. URL: https://www.who.int/ru/news-room/fact-sheets/detail/cervical-cancer. (Accessed: 23.01.2025).
- Cervical cancer. 05.03.2024 // World Health Organization. [Electronic resource]. URL: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. (Accessed: 23.01.2025).
- Murithi Gatumo, Susan Gacheri, Abdul-Rauf Sayed, Andrew Scheibe. Women’s knowledge and attitudes related to cervical cancer and cervical cancer screening in Isiolo and Tharaka Nithi counties, Kenya: a cross-sectional study. BMC Cancer. 2018 Jul 18; 18:745. doi: 10.1186/s12885-018-4642-9.
- Ustinova L. N. Cervical cancer // FGBU FNKTS FMBA of Russia. [Electronic resource]. URL: https://fnkc-fmba.ru/zabolevaniya/rak-sheyki-matki/. (Accessed: 23.01.2025).
- Cervical Cancer Prognosis and Survival Rates. 27.04.2023 // National Cancer Institute. [Электронный ресурс]. URL: https://www.cancer.gov/types/cervical/survival. (Дата обращения: 23.01.2025).
- Clinical guidelines of the Ministry of Health of the Russian Federation. Cervical intraepithelial neoplasia, erosion, and ectropion of the cervix. Year of approval: 2024.
- Shumina A. V. Precancerous conditions as the zero stage of cervical cancer. 18.10.2018 // MU "Polyclinic of FNPR". [Electronic resource]. URL: https://medfnpr.ru/about/articles/predrakovye-zabolevaniya-kak-nulevaya-stadiya-raka-sheyki-matki/. (Accessed: 23.01.2025).
- Colposcopy and early diagnosis of cervical pathology. 21.03.2018. // Taganrog Branch of the State Budgetary Healthcare Institution of Rostov Region "Oncological Dispensary". [Electronic resource]. URL: https://onkotgn.ru/articles/kolposkopiya-i-rannyaya-diagnostika-patologii-sheyki-matki/. (Accessed: 23.01.2025).
- Uzdenova S. A. HPV (Human Papillomavirus) // FGBU FNKTS FMBA of Russia. [Electronic resource]. URL: https://fnkc-fmba.ru/zabolevaniya/vpch/. (Accessed: 23.01.2025).
- The StayWell Company, LLC (мед. рецензенты: Goodman, H., MD; Watson, L.R., MSN, RN). Cervical Cancer Risk Assessment // University of Rochester Medical Center [Электронный ресурс]. URL: https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=42&contentid=cervicalcancerrisk. (Дата обращения: 09.02.2026).
- Gynecological screening: everything a woman needs to know about her health. 10.07.2024 // FGBU "NMIC Radiology" of the Ministry of Health of Russia. [Electronic resource]. URL:https://new.nmicr.ru/news/ginekologicheskij-skrining-vse-chto-nuzhno-znat-zhenshhine-o-svoem-zdorove/(Accessed: 23.01.2025).
- Prevention of cervical cancer. 22.04.2019 // GUZ "Saratov City Clinical Hospital No. 9". [Electronic resource]. URL: https://9sargb.ru/news/Profilaktika_raka_sheyki_matki/(Accessed: 23.01.2025).
- Kiselev V.I., Ashrafyan L.A., et al. Clinical study on the effectiveness of suppositories 'Cervikon-DIM' in the treatment of cervical intraepithelial neoplasia of mild and moderate degrees. Bulletin of the Russian Scientific Center for Radiology and Radiology of the Ministry of Health of Russia. 2014; 14-36.
- Sukhikh G.T., Ashrafyan L.A., et al. Study of the efficacy and safety of a diindolylmethane-based drug in patients with cervical intraepithelial neoplasia (CIN 1–2). Obstetrics and Gynecology. 2018; 9: 91-8.
- Kiselev V.I., Muizhnek E.L., Ashrafyan L.A., Sukhikh G.T. New paradigm of cervical neoplasia progression: from fundamental knowledge to practical gynecology. Obstetrics and Gynecology. 2019.